9363702
|
Ciampelli M
|
1997
|
Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.
|
9363711
|
Tadokoro N
|
1997
|
Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme.
|
9364254
|
Lupoli G
|
1997
|
Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass.
|
9369189
|
Lambert-Messerlian G
|
1997
|
Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation.
|
9385529
|
Takeuchi T
|
1997
|
Effect of growth hormone suppression on the serum levels of ovarian and adrenal sex steroid hormones in normal women and in women with polycystic ovary syndrome.
|
9385530
|
Mici? D
|
1997
|
Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome.
|
9396280
|
Tsutsumi O
|
1997
|
[Abnormal female reproductive function].
|
9396305
|
Kitaoka Y
|
1997
|
[Polycystic ovary syndrome: PCOS].
|
9398716
|
Nestler JE
|
1997
|
Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens.
|
9403321
|
Nestler JE
|
1997
|
Insulin regulation of human ovarian androgens.
|
9403322
|
Scheen AJ
|
1997
|
Perspective in the treatment of insulin resistance.
|
9403323
|
Lefebvre P
|
1997
|
Influences of weight, body fat patterning and nutrition on the management of PCOS.
|
9403324
|
Pasquali R
|
1997
|
Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome.
|
9403325
|
Galtier-Dereure F
|
1997
|
Choice of stimulation in polycystic ovarian syndrome: the influence of obesity.
|
9404439
|
Rosenfield RL
|
1997
|
Is polycystic ovary syndrome a neuroendocrine or an ovarian disorder?
|
9408743
|
Dunaif A
|
1997
|
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
|
9410809
|
Mason M
|
1997
|
[The proportion of molecular forms of gonadotropins changes in patients with polycystic ovaries].
|
9413805
|
Murialdo G
|
1997
|
Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy.
|
9414438
|
Franks S
|
1996
|
Nutrition, insulin and polycystic ovary syndrome.
|
9418684
|
Tropeano G
|
1997
|
Effects of oral glucose administration on plasma growth hormone levels in women with polycystic ovary syndrome.
|
9419751
|
Schriock ED
|
1994
|
Enhanced post-receptor insulin effects in women following dehydroepiandrosterone infusion.
|
9420860
|
Palumbo A
|
1995
|
Apoptosis as a basic mechanism in the ovarian cycle: follicular atresia and luteal regression.
|
9420861
|
Diamanti-Kandarakis E
|
1995
|
Androgens and therapeutic aspects of antiandrogens in women.
|
9420884
|
Carmina E
|
1995
|
Altered regulation of insulin-like growth factor binding protein-1 in patients with polycystic ovary syndrome.
|
9425584
|
Sharma S
|
1997
|
Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
|
9429701
|
Liddell HS
|
1997
|
Recurrent miscarriage: screening for polycystic ovaries and subsequent pregnancy outcome.
|
9429864
|
Goudas VT
|
1997
|
Polycystic ovary syndrome.
|
9433961
|
Balen A
|
1997
|
Anovulatory infertility and ovulation induction. Policy and Practice subcommittee of the British Fertility Society.
|
9435423
|
De Leo V
|
1998
|
Hormonal effects of flutamide in young women with polycystic ovary syndrome.
|
9436663
|
Damario MA
|
1997
|
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
|
9436665
|
Kaaijk EM
|
1997
|
Unilateral oophorectomy in polycystic ovary syndrome: a treatment option in highly selected cases?
|
9436687
|
Lin Y
|
1997
|
Insulin stimulation of lactate accumulation in isolated human granulosa-luteal cells: a comparison between normal and polycystic ovaries.
|
9437235
|
Sahin Y
|
1997
|
The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome.
|
9437670
|
Marantides D
|
1997
|
Management of polycystic ovary syndrome.
|
9438919
|
Ruiz A
|
1997
|
Serum levels of GH, IGF-I, LH and ovarian steroids in cyclic and RU486-treated rats.
|
9440305
|
Ch?vez-Ross A
|
1997
|
Modelling the control of ovulation and polycystic ovary syndrome.
|
9441866
|
Witchel SF
|
1997
|
Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency.
|
9444888
|
Irwin M
|
1998
|
Valproate and polycystic ovaries.
|
9447454
|
Vrtacnik-Bokal E
|
1997
|
Short-term GnRH-analogue administration in patients with PCOS and its impact on hemodynamics and hormonal profile.
|
9451521
|
Lunenfeld B
|
1997
|
An overview of obesity during puberty, adolescence and reproduction.
|
9452898
|
Slupik RI
|
1998
|
Case studies in contraception.
|
9452956
|
Bertschy S
|
1998
|
Selective immunocytochemical localisation of calretinin in the human ovary.
|
9454393
|
Ovesen PG
|
1998
|
[Polycystic ovary syndrome I. Clinical presentation and treatment].
|
9454394
|
Ovesen PG
|
1998
|
[Polycystic ovary syndrome II. Endocrinology and metabolism].
|
9455828
|
Franks S
|
1997
|
The genetic basis of polycystic ovary syndrome.
|
9457128
|
Edozien L
|
1998
|
Length of gestation and polycystic ovaries in adulthood.
|
9457129
|
van Hooff MH
|
1998
|
Length of gestation and polycystic ovaries in adulthood.
|
9457942
|
Liao WX
|
1998
|
A new molecular variant of luteinizing hormone associated with female infertility.
|
9459090
|
Tulandi T
|
1997
|
Reproductive performance and three-dimensional ultrasound volume determination of polycystic ovaries following laparoscopic ovarian drilling.
|
9463180
|
Falsetti L
|
1997
|
[Finasteride and flutamide in the treatment of hirsutism].
|
9467551
|
Van Der Meer M
|
1998
|
Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome.
|
9467578
|
Pastor CL
|
1998
|
Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
|
9471896
|
Nalbanski B
|
1997
|
[Laparoscopic fenestration of the ovaries].
|
9472960
|
Invitti C
|
1998
|
Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome.
|
9472963
|
Fulghesu AM
|
1998
|
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.
|
9475386
|
Lee GY
|
1998
|
Multidrug resistance gene expression correlates with progesterone production in dehydroepiandrosterone-induced polycystic and equine chorionic gonadotropin-stimulated ovaries of prepubertal rats.
|
9477644
|
Z?rate A
|
1997
|
[Use of metformin in the management of adolescents with polycystic ovary syndrome].
|
9480574
|
Spremovi?-Radjenovi? S
|
1997
|
[The polycystic ovary syndrome associated with ovarian tumor].
|
9481555
|
de Vries MJ
|
1998
|
Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study.
|
9488580
|
Pelosi MA
|
1998
|
Simultaneous laparoscopic surgical treatments.
|
9489102
|
Salzmann J
|
1997
|
Central retinal vein occlusion associated with the polycystic ovarian syndrome.
|
9490171
|
Kreze A Jr
|
1997
|
[The polycystic ovary syndrome and insulin resistance].
|
9490599
|
Schlechte JA
|
1998
|
Update in endocrinology.
|
9492722
|
Bergh C
|
1998
|
Results of gonadotrophin stimulation with the option to convert cycles to in vitro fertilization in cases of multifollicular development.
|
9496335
|
Atiomo WU
|
1998
|
The plasminogen activator system in women with polycystic ovary syndrome.
|
9496351
|
Duleba AJ
|
1998
|
Insulin and insulin-like growth factor I stimulate the proliferation of human ovarian theca-interstitial cells.
|
9502773
|
Pincus SM
|
1998
|
Follicle-stimulating hormone is secreted more irregularly than luteinizing hormone in both humans and sheep.
|
9509072
|
Klinger B
|
1998
|
Development of hyperandrogenism during treatment with insulin-like growth factor-I (IGF-I) in female patients with Laron syndrome.
|
9510005
|
Jakimiuk AJ
|
1998
|
Aromatase mRNA expression in individual follicles from polycystic ovaries.
|
9512218
|
van Montfrans JM
|
1998
|
Treatment of hyperinsulinaemia in polycystic ovary syndrome?
|
9512222
|
Kaltsas T
|
1998
|
Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome.
|
9529684
|
Young R
|
1998
|
Hirsutes. I: Diagnosis.
|
9532832
|
Gregorini SD
|
1997
|
[Endometrial carcinoma with polycystic ovaries. Report of two cases in women younger than 40 years old].
|
9532997
|
Li TC
|
1998
|
Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility.
|
9536211
|
Mason H
|
1997
|
Local control of ovarian steroidogenesis.
|
9536213
|
Rosenfield RL
|
1997
|
Current concepts of polycystic ovary syndrome.
|
9536214
|
Ehrmann DA
|
1997
|
Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus.
|
9536215
|
Dewailly D
|
1997
|
Definition and significance of polycystic ovaries.
|
9536216
|
Barnes RB
|
1997
|
Diagnosis and therapy of hyperandrogenism.
|
9539295
|
Pasquali R
|
1998
|
Insulin sensitizing agents and polycystic ovary syndrome.
|
9539300
|
Diamanti-Kandarakis E
|
1998
|
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
|
9542361
|
Lin KC
|
1998
|
Characterization of pulsatile secretion of gonadotropin and prolactin in women with normal menstrual cycle, secondary amenorrhea and polycystic ovary syndrome (PCOS).
|
9543131
|
Holte J
|
1998
|
High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus.
|
9546324
|
Isoj?rvi JI
|
1998
|
Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
|
9548158
|
Okon MA
|
1998
|
Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function.
|
9548159
|
Morin-Papunen LC
|
1998
|
Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.
|
9548160
|
Gj?nnaess H
|
1998
|
Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome.
|
9549840
|
Lees C
|
1998
|
Unexpected effect of a nitric oxide donor on uterine artery Doppler velocimetry in oligomenorrheic women with polycystic ovaries.
|
9551368
|
Udoff LC
|
1996
|
Polycystic ovarian disease: current insights into an old problem.
|
9557226
|
Henze C
|
1998
|
Incidence of increased androgen levels in patients suffering from acne.
|
9557824
|
Doldi N
|
1998
|
Polycystic ovary syndrome: anomalies in progesterone production.
|
9564642
|
Erg?r AR
|
1998
|
Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
|
9565144
|
Vegetti W
|
1998
|
Ovarian stimulation with low-dose pure follicle-stimulating hormone in polycystic ovarian syndrome anovulatory patients: effect of long-term pretreatment with gonadotrophin-releasing hormone analogue.
|
9565843
|
Lessey BA
|
1998
|
Embryo quality and endometrial receptivity: lessons learned from the ART experience.
|
9572406
|
Gennarelli G
|
1998
|
Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?
|
9572407
|
Paradisi G
|
1998
|
Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy.
|
9572412
|
Dale PO
|
1998
|
The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
|
9572428
|
Agrawal R
|
1998
|
Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.
|
9578510
|
Falsetti L
|
1998
|
Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women.
|
9579228
|
Adami S
|
1998
|
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women.
|